- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 6.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.47M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 5.05M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $105K |
| Capex | Q1 2026 · Mar 31, 2025 | $17K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.58M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$6.72M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $57.82M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $11.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $57.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$21.09M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.1M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $20.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.77M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $20.86M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $59.15M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $50.23M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $60M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $51.26M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $12.46 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.54 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $12.69 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.54 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.2M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.11M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $965K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $971K |
| Net Income | Q1 2026 · Mar 31, 2026 | $80.58M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.76M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.91M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.09M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $253K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | −$8K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $193K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $8K |